Csenge Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.75M | Buy |
|
|||||
|
2025
Q2 | $2.13M | Buy |
|
|||||
|
2025
Q1 | $1.99M | Buy |
|
|||||
|
2024
Q4 | $1.6M | Buy |
|
|||||
|
2024
Q3 | $1.17M | Buy |
|
|||||
|
2024
Q2 | $995K | Buy |
|
|||||
|
2024
Q1 | $634K | Sell |
|
|||||
|
2023
Q4 | $800K | Buy |
|
|||||
|
2023
Q3 | $725K | Buy |
|
|||||
|
2023
Q2 | $344K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $202K | Sell |
|
|||||
|
2020
Q4 | $233K | Sell |
|
|||||
|
2020
Q3 | $252K | Buy |
|
|||||
|
2020
Q2 | $250K | Sell |
|
|||||
|
2020
Q1 | $282K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1K | Buy |
|